Blackstone Group »

Sab Biotherapeutics shares owned by Blackstone Group

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.0M 2.1M 3.74

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
Corebridge Finl (CRBG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
FirstEnergy (FE)
Legence Corp Cl A (LGN)
Williams Companies (WMB)
EQT Corporation (EQT)
MPLX Com Unit Rep Ltd (MPLX)
Cheniere Energy Com New (LNG)
Enbridge (ENB)
Targa Res Corp (TRGP)
Enterprise Products Partners (EPD)
Kinder Morgan (KMI)
Ishares Tr Russell 2000 Etf (IWM)
PNM Resources (TXNM)

View all positions for Blackstone Group

Top funds holding Sab Biotherapeutics

Vivo Capital
Commodore Capital
RA Capital Management
Woodline Partners
Sessa Capital IM
Blackstone Group
Vanguard Group
Perceptive Advisors
Propel Bio Management
Leucadia National Corporation
Balyasny Asset Management
Millennium Management
HB Wealth Management
Ameriprise Financial
Marshall Wace

View all funds holding Sab Biotherapeutics